SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-031107
Filing Date
2022-02-08
Accepted
2022-02-08 17:02:30
Documents
1
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LPBCLS II INVESTCO, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d252776dsc13da.htm SC 13D/A 62438
  Complete submission text file 0001193125-22-031107.txt   64068
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90033 | Film No.: 22602452
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Fund II, L.P. (Filed by) CIK: 0001773187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A